Home > Publications > Media Centre > Media Releases
Centenary Institute - Medical Research
Centenary Institute - Medical Research

Media Releases

Orchid extract holds hope for prostate cancer treatment


Research led by the Centenary Institute has found that a compound extracted from a commonly cultivated orchid could be a potential new treatment option for prostate cancer. The second most common form of cancer, prostate cancer is also the sixth highest cause of cancer-related mortality worldwide.

Centenary Institute supports NSW RNA push


The Centenary Institute is pleased to note its involvement in, and support of, the newly announced NSW RNA Production and Research Network involving the state’s leading universities and other prominent health and medical research organisations.

Cell death discovery could lead to new treatment for COPD


Research shows that inhibiting necroptosis, a form of cell death, could be a novel therapeutic approach for treating chronic obstructive pulmonary disease (COPD), an inflammatory lung condition, also known as emphysema, that makes it difficult to breathe.

Boost to world-class melanoma research


World-class research into melanoma, the deadliest form of skin cancer, has been boosted with Dr Jessamy Tiffen, Head of the Centenary Institute’s ‘Melanoma Epigenetics Laboratory’, receiving a $447,000 project grant from Cancer Council NSW.

MRFF grant to help fast-track Australian COVID-19 vaccine candidate


A collaborative project involving the University of Sydney, the Centenary Institute, the University of Technology Sydney and the Kirby Institute at UNSW Sydney, has received funding from the Medical Research Future Fund (MRFF) to continue work on the development of a unique, single-shot vaccine against COVID-19 variants of concern.

Gene discovery suggests new treatment approach for liver cancer


In a comprehensive analysis of human gene activation data, researchers from the Centenary Institute have discovered that the dipeptidyl peptidase-4 (DPP4) gene family is strongly implicated in the development of human hepatocellular carcinoma (HCC), the most common type of primary liver cancer.

Dual drug approach to treat deadly melanoma


Research from the Centenary Institute has found that a new dual drug approach could offer up a highly effective treatment strategy for melanoma, the most serious form of skin cancer responsible for more than 1,700 deaths each year in Australia.

Multiple sclerosis drug research funded


Associate Professor Anthony Don, Head of the Lipid Metabolism and Neurochemistry Laboratory at the Centenary Institute has received a funding grant of $115,000 from MS Research Australia to help investigate and develop drugs that can better treat multiple sclerosis (MS).

Prestigious grants success for Centenary Institute researchers


World-leading research into sudden cardiac death (SCD) in young people and multiple sclerosis has been boosted with two Centenary Institute researchers successfully securing prestigious NHMRC Ideas Grants.

Gut microbiome link to deadly lung disease


Research led by the Centenary Institute, the University of Technology Sydney and the University of Queensland has shown for the first time a link between chronic obstructive pulmonary disease (COPD), an often fatal lung condition, and the gut microbiome.